Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Immune Response Testing Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The market for immune response testing has experienced substantial expansion lately. Projections indicate a rise from $16.36 billion in 2025 to $18.09 billion by 2026, reflecting a compound annual growth rate of 10.6%. This accelerated growth during the past period is largely due to a greater incidence of immune system-related ailments, augmented application of diagnostics relying on antibodies, the proliferation of clinical immunology facilities, a greater embrace of ELISA testing techniques, and enhanced surveillance of vaccine efficacy.
The realm of immune response testing is poised for significant expansion over the coming years, projecting an increase to $26.76 billion by the year 2030, propelled by a compound annual growth rate of 10.3%. This anticipated surge is underpinned by several key drivers, including a heightened need for individualized immune profiling, greater utilization of immune monitoring within oncology and vaccine development, the broader availability of point-of-care immune testing solutions, the increasing incorporation of artificial intelligence for diagnostic interpretation, and a strengthening emphasis on identifying immune dysfunctions at their earliest stages. Emerging trends anticipated during this forecast period encompass a greater embrace of multiplex immune assays, a rise in the application of cellular immune response analysis, the wider integration of automated testing platforms, the development of more sensitive diagnostic panels, and a more pronounced focus on ongoing immune monitoring.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27314&type=smp
Immune Response Testing Market Growth Momentum: Which Factors Are Influencing Demand?
The increasing incidence of autoimmune disorders is anticipated to fuel the expansion of the immune response testing sector. Autoimmune disorders are characterized by the immune system erroneously targeting the body’s own healthy cells and tissues. A primary driver behind the escalating rates of these conditions is heightened exposure to environmental contaminants, which can impair immune function and incite self-directed immune assaults. Immune response testing facilitates improved management of autoimmune diseases by offering accurate information about the immune system’s activity, thereby allowing for earlier detection and customized therapeutic strategies. This testing aids in more effective disease surveillance and contributes to better patient results through fine-tuned treatment modifications. Illustratively, as reported by Arthritis Australia in February 2024, an estimated 562,378 individuals in Australia will be affected by rheumatoid arthritis (RA) in 2025, constituting 14% of all arthritis diagnoses for that year. Projections indicate a 33% increase by 2040, bringing the total to 748,721 individuals, an advancement of 186,343 Australians with RA compared to the 2025 estimate. Consequently, the growing ubiquity of autoimmune diseases is a key factor spurring the growth of the immune response testing market.
Immune Response Testing Market Segment Breakdown: Which Categories Generate The Most Revenue?
The immune response testing market covered in this report is segmented –
1) By Type Of Testing: Antibody Testing, Cytokine Testing, Cellular Testing, Complement System Testing
2) By Application: Allergy Testing, Human Immunodeficiency Virus (HIV) Disease, Cancer, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Other Applications
3) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings
Subsegments:
1) By Antibody Testing: Immunoglobulin G (IgG) Testing, Immunoglobulin A (IgA) Testing, Immunoglobulin M (IgM) Testing, Neutralizing Antibody Testing, Rapid Antibody Testing
2) By Cytokine Testing: Enzyme-Linked Immunosorbent Assay (ELISA)-Based Cytokine Assays, Multiplex Cytokine Assays, Flow Cytometry-Based Cytokine Assays, Cytometric Bead Array, Quantitative Polymerase Chain Reaction (qPCR)-Based Cytokine Analysis
3) By Cellular Testing: T-Cell Response Assays, B-Cell Response Assays, Natural Killer (NK) Cell Assays, Lymphocyte Proliferation Assays, ELISpot Assays
4) By Complement System Testing: Total Hemolytic Complement (CH50) Assay, Alternative Pathway Hemolytic Complement (AH50) Assay, Complement Component 3 And 4 (C3 And C4) Complement Testing, Mannose-Binding Lectin (MBL) Testing, Complement Activity Assays
Immune Response Testing Market Trends Reshaping Industry Growth
Leading entities within the Immune Response Testing sector are concentrating on pioneering advancements, exemplified by immune profiling technologies, to address the escalating need for sophisticated diagnostic tools in evaluating post-viral conditions and adaptive immunity. These immune profiling technologies offer a holistic examination of the immune system, scrutinizing both cellular and fluid-based immune reactions, thereby yielding richer information than conventional serological tests that primarily gauge antibody concentrations. As an illustration, in April 2024, Virax Biolabs Group Limited, a biotechnology firm headquartered in the United Kingdom, unveiled its suite of immune profiling offerings at ESCMID Global 2024, aimed at assessing adaptive immunity in the aftermath of viral infections. These integrated solutions incorporate cutting-edge assays, such as highly detailed flow cytometry and specific biomarker panels, facilitating a precise delineation of immune cell populations and their functional activities, boasting superior sensitivity, adaptable panels for diverse post-viral ailments, and compatibility with digital reporting systems for simplified data analysis, with uses spanning clinical studies to individualized patient care, facilitating advantages like the prompt identification of immune system irregularities and guidance for treatment choices.
Immune Response Testing Market Key Players And Strategic Industry Positioning
Major companies operating in the immune response testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Quest Diagnostics Incorporated, Eurofins Scientific SE, PerkinElmer Inc., bioMérieux SA, Bruker Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., EUROIMMUN Medizinische Labor diagnostika AG, NanoString Technologies Inc., GenScript Biotech Corporation, Cell Signaling Technology Inc., Sysmex Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd., Merck KGaA
Access The Complete Immune Response Testing Market Report:
https://www.thebusinessresearchcompany.com/report/immune-response-testing-global-market-report
Immune Response Testing Market Regional Outlook: Where Are The Largest Opportunities Located?
North Americawas the largest region in the immune response testing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the immune response testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
